Biomedical

The Campus Biometropolis development will be constructed in Mexico City. Designed by Foster + Partners, the 71 hectare medical city will include research, instructional, and healthcare facilities. The mixed-use project will contain a hospital, laboratories, offices, a conference center, a hotel, shops, and apartments. The campus will accommodate companies focused on six key areas of medicine: cancer, cardiovascular, infectious diseases, pharmaceuticals, nutrition, and geriatrics.

The University of Illinois College of Medicine is planning to construct a 24,000-sf cancer research center in Peoria. Construction will begin on the $13 million facility by summer of 2010.

Oregon Health & Science University will begin construction in February of 2010 on the Vaccine and Gene Therapy Institute in Port St. Lucie, Fla. Located in the Florida Center for Innovation research park in Tradition, the 98,000-sf laboratory is slated for completion in fall of 2011. The general contractor for the four-story building is Whiting-Turner Contracting Co. of Tampa.

Fisher & Paykel Healthcare will break ground in early 2010 on a research and development facility in Auckland, New Zealand. The building will house laboratories, offices, manufacturing facilities, and warehouse space. Completion is expected in late 2012.

The University of Minnesota opened the $69.5 million Medical Biosciences Building in Minneapolis in December of 2009. Designed by Perkins and Will, the 115,000-gsf facility was built by Kraus-Anderson with Sebesta Blomberg as infrastructure engineer. Housing medical research laboratories, offices, and conference space, the facility will support interdisciplinary collaborative research in immunology, neuroscience, cancer research, and infectious diseases. Ground was broken on the project in summer of 2007.

Van Andel Institute celebrated the opening of its $175 million Phase II Expansion in Grand Rapids, Mich., in early December of 2009. Designed by Rafael Viñoly, the 242,000-sf medical research and education facility is comprised of eight floors of labs and offices supporting basic and translational research. The sustainably-designed facility was built by a joint venture of Owen-Ames-Kimball Company and The Hunt Construction Group.

Newsom Eye & Laser began construction in November of 2009 on a 4,600-sf eye surgery center in Tampa, Fla. Featuring operating rooms designed to meet the required standards for FDA research studies, the facility is part of a $7.5 million expansion of Newsom’s existing campus. Completion is expected in spring of 2010.

Site work has begun on Weill Cornell Medical College's $650 million Medical Research Building in New York. The 480,000-sf facility will feature a Cancer Center supporting interdisciplinary and translational research. Laboratories will occupy 13 floors of the building. Completion is expected in July of 2013.

Site work began in fall of 2009 on the Parkville Comprehensive Cancer Centre in Melbourne, Victoria. Delivered as a public-private partnership, the $1 billion facility will support collaborative research for the University of Melbourne, the Peter McCallum Cancer Centre, the Ludwig Institute for Cancer Research, Melbourne Health, the Royal Melbourne Hospital, the Walter and Eliza Hall Institute of Medical Research, and the Royal Women’s Hospital.

The University of Hawaii has initiated the design phase for the $120 million Cancer Research Center of Hawaii in Kakaako. Construction is expected to begin in summer of 2010. The project manager is Kobayashi Group with Skyline Construction as designer and developer. Wilson Okamoto and Associates will provide project planning services. The facility is expected to open in 2013.

Northwestern University dedicated the $100 million Richard and Barbara Silverman Hall for Molecular Therapeutics and Diagnostics in Evanston, Ill., in November of 2009. The 147,000-gsf interdisciplinary research facility houses the Chemistry of Life Processes Institute and approximately 245 researchers and staff from the physical sciences, life sciences, and engineering. Comprised of four stories above ground and one below, Silverman Hall will support collaborative biomedical research and the creation of new medicines and technologies.

CPL Biologicals broke ground in fall of 2009 on an influenza vaccine manufacturing facility in Ahmedabad, India. The 25,000-sf building will be operational in the first quarter of 2010. The facility will use virus-like particle (VLP) vaccine technology to produce commercial-scale quantities of VLP-based influenza vaccines. The plant will be able to produce over 60 million doses annually at full capacity. CPL Biologicals is a joint venture of Novavax and Cadila Pharmaceuticals of India.

Indiana University School of Medicine initiated construction in October of 2009 on the Eugene and Marilyn Glick Eye Institute in Indianapolis. Housing the Department of Ophthalmology, the 70,000-sf facility will include biomedical research laboratories, classrooms, faculty offices, and an outpatient clinic. The Glick Eye Institute was designed by RATIO Architects of Indianapolis. LEED Gold sustainable design certification will be sought for the project.

The M.D. Anderson–Orlando Cancer Research Institute opened its 30,000-sf research laboratory in Orlando in October of 2009. The wet lab facility is located on the fifth floor of the University of Central Florida’s Burnett School of Biomedical Sciences building in the Lake Nona medical research district.  

The Medical Research Council is planning to construct the 2.4 million-sf Cambridge Biomedical Campus in Cambridge in the United Kingdom. The project will be developed by Cambridge University Hospitals NHS Foundation Trust, Countryside Properties, and Liberty Property Trust. Housing facilities for biomedical research, clinical treatment, and instruction, the £900 million project will be located adjacent to the 270,000-sf Laboratory of Molecular Biology currently under construction at the site.